In silico screening for human norovirus antivirals reveals a novel non-nucleoside inhibitor of the viral polymerase
Abstract Human norovirus causes approximately 219,000 deaths annually, yet there are currently no antivirals available. A virtual screening of commercially available drug-like compounds (~300,000) was performed on the suramin and PPNDS binding-sites of the norovirus RNA-dependent RNA polymerase (RdR...
Guardado en:
Autores principales: | Salvatore Ferla, Natalie E. Netzler, Sebastiano Ferla, Sofia Veronese, Daniel Enosi Tuipulotu, Salvatore Guccione, Andrea Brancale, Peter A. White, Marcella Bassetto |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/77b2d570609640eb84832ed1a696b6b2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Norovirus Polymerase Fidelity Contributes to Viral Transmission <italic toggle="yes">In Vivo</italic>
por: Armando Arias, et al.
Publicado: (2016) -
Carbon Dots’ Antiviral Functions Against Noroviruses
por: Xiuli Dong, et al.
Publicado: (2017) -
Structural understanding of non-nucleoside inhibition in an elongating herpesvirus polymerase
por: Robert P. Hayes, et al.
Publicado: (2021) -
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
por: Maria L. Agostini, et al.
Publicado: (2018) -
Structural basis for polymerase η–promoted resistance to the anticancer nucleoside analog cytarabine
por: Olga Rechkoblit, et al.
Publicado: (2018)